We are live on ! Find out more
LC

Lindbrook Capital Portfolio holdings

AUM $1.08B
1-Year Est. Return 10.14%
This Fund
S&P 500
This Quarter Est. Return
+10.25%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
AUM
$1.07B
AUM Growth
+$67.5M
Cap. Flow
-$16.8M
Cap. Flow %
-1.57%
Top 10 Hldgs %
43.59%
Holding
2,793
New
103
Increased
1,023
Reduced
644
Closed
145

Sector Composition

Rank Sector Weight
1 Technology 15.66%
2 Financials 13.81%
3 Healthcare 6.79%
4 Consumer Discretionary 3.87%
5 Communication Services 3.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GOOG icon
26
Alphabet (Google) Class C
GOOG
$4.32T
$7.22M 0.68%
47,405
+234
+0.5% +$33.8K
JPM icon
27
JPMorgan Chase
JPM
$950B
$7.02M 0.66%
35,052
-1,022
-3% -$184K
IJR icon
28
iShares Core S&P Small-Cap ETF
IJR
$112B
$6.86M 0.64%
62,038
-100
-0.2% -$10.6K
PEP icon
29
PepsiCo
PEP
$190B
$6.8M 0.64%
38,840
-510
-1% -$85.9K
UNH icon
30
UnitedHealth
UNH
$370B
$6.77M 0.63%
13,694
-365
-3% -$186K
AXSM icon
31
Axsome Therapeutics
AXSM
$10.9B
$6.68M 0.63%
83,768
-318
-0.4% -$26.7K
BRK.B icon
32
Berkshire Hathaway Class B
BRK.B
$1.13T
$6.28M 0.59%
14,940
+912
+7% +$359K
BXMX
33
DELISTED
Nuveen S&P 500 Buy-Write Income Fund
BXMX
$6.03M 0.56%
456,130
+5,866
+1% +$76.5K
PPA icon
34
Invesco Aerospace & Defense ETF
PPA
$8.7B
$5.5M 0.51%
54,153
-350
-0.6% -$33.2K
IYJ icon
35
iShares US Industrials ETF
IYJ
$2.02B
$5.45M 0.51%
43,383
-270
-0.6% -$31.9K
TMO icon
36
Thermo Fisher Scientific
TMO
$220B
$5.4M 0.51%
9,291
+126
+1% +$70.7K
FDN icon
37
First Trust Dow Jones Internet Index Fund ETF
FDN
$5.45B
$5.36M 0.5%
26,154
-479
-2% -$94.5K
HON icon
38
Honeywell
HON
$78B
$5.14M 0.48%
26,559
-652
-2% -$123K
VO icon
39
Vanguard Morningstar Mid-Cap ETF
VO
$109B
$5.13M 0.48%
82,080
-4,040
-5% -$239K
XBI icon
40
State Street SPDR S&P Biotech ETF
XBI
$10.3B
$5.08M 0.48%
53,528
+5,573
+12% +$517K
NMFC icon
41
New Mountain Finance
NMFC
$732M
$4.91M 0.46%
387,320
-5,965
-2% -$76K
LLY icon
42
Eli Lilly
LLY
$1.06T
$4.9M 0.46%
6,294
+136
+2% +$96.8K
VCR icon
43
Vanguard Consumer Discretionary ETF
VCR
$6.33B
$4.83M 0.45%
15,215
-95
-0.6% -$29K
CME icon
44
CME Group
CME
$94.8B
$4.36M 0.41%
20,240
-934
-4% -$196K
VB icon
45
Vanguard Morningstar Small-Cap ETF
VB
$82.4B
$4.16M 0.39%
18,210
-3,199
-15% -$688K
XLK icon
46
State Street Technology Select Sector SPDR ETF
XLK
$124B
$4.15M 0.39%
39,888
-1,688
-4% -$171K
SNAP icon
47
Snap
SNAP
$9.01B
$4.08M 0.38%
355,326
+354,533
+44,708% +$4.75M
VOO icon
48
Vanguard S&P 500 ETF
VOO
$1.01T
$4.06M 0.38%
8,440
+99
+1% +$45.3K
CHI
49
Calamos Convertible Opportunities and Income Fund
CHI
$1.05B
$4.05M 0.38%
356,531
-6,415
-2% -$69.8K
VTV icon
50
Vanguard Morningstar Value ETF
VTV
$191B
$4.03M 0.38%
24,758
+330
+1% +$50.9K

Similar funds

Lindbrook Capital's Q1 2024 Portfolio in Review

As of Q1 2024, Lindbrook Capital held 2,793 positions worth $1.07B, up 6.7% from $1B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Lindbrook Capital's Q1 2024 filing shows 103 new, 1,023 increased, 644 reduced and 145 closed positions. Its largest new stake was Hess Midstream: 14,335 shares worth $518K. The largest sale was Golub Capital BDC, an estimated $15.8M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Financials and Healthcare.

  • Lindbrook Capital's largest Q1 2024 buy was Hess Midstream: 14,335 shares worth $518K.
  • Lindbrook Capital added most to Vertex Pharmaceuticals in Q1 2024, an estimated $8.03M increase.
  • Lindbrook Capital's biggest Q1 2024 reduction was Golub Capital BDC, cutting an estimated $15.8M.
  • Lindbrook Capital fully exited Splunk Inc in Q1 2024, selling an estimated $153K.
  • Lindbrook Capital's ten largest holdings make up 44% of its $1.07B portfolio in Q1 2024.
  • Lindbrook Capital opened 103 new positions and closed 145 in Q1 2024.
  • Lindbrook Capital's portfolio value rose 6.7% quarter-over-quarter to $1.07B.

Based on Lindbrook Capital's 13F filing for Q1 2024, filed 25 Apr 2024.